Intelligence · Clinical Development
Pipeline search results
Programs matching “carboplatin” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 29 pipeline programs matching "carboplatin" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
CISPLATIN, CARBOPLATIN
Cardiff Oncology
Human papillomavirus (HPV)-positive oropharyngeal cancer
1 trial -
Carboplatin
Alaunos Therapeutics
Extensive-Stage Small Cell Lung Cancer
1 trial -
Carboplatin
Teva Pharma GmbH
Tubular Breast Cancer Stage II
1 trial -
Carboplatin
Hoffmann-La Roche
Breast Neoplasms
1 trial -
Carboplatin
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Obatoclax Mesylate, Carboplatine and Etoposide
Teva Pharma GmbH
Extensive-stage Small Cell Lung Cancer
1 trial -
Paclitaxel or docetaxel + Cisplatin or carboplatin
The First People's Hospital of Lianyungang
Uterine Cervical Neoplasms
1 trial -
nab-paclitaxel combined with carboplatin
The First People's Hospital of Lianyungang
Epithelial Ovarian Carcinoma Stage III
1 trial -
20170512
The First People's Hospital of Lianyungang
Triple-Negative Breast Cancer
1 trial -
2024-HS-022
The First People's Hospital of Lianyungang
Platinum-sensitive Relapsed Ovarian Cancer
1 trial -
Apatinib
The First People's Hospital of Lianyungang
Systematic Review of the pCR Rate of Apatinib Combined With Albumin Paclitaxel and Carboplatin Regimen for Neoadjuvant Therapy of Triple-negative Breast Cancer
1 trial -
Carboplatin
Children's Hospital of Fudan University
Desmoplastic/Nodular Medulloblastoma
1 trial -
Carboplatin
Children's Hospital of Fudan University
Central Nervous System Nongerminomatous Germ Cell Tumor
1 trial -
Carboplatin
United Therapeutics Europe Ltd
Hormone Refractory Prostate Cancer
1 trial -
Carboplatin
United Therapeutics Europe Ltd
Recurrent Fallopian Tube Carcinoma
1 trial -
Carboplatin
Atrium Therapeutics
Lung Cancer Stage II
1 trial -
Carboplatin
Teva Pharma GmbH
Prostatic Neoplasm
1 trial -
Carboplatin plus Paclitaxel
United Therapeutics Europe Ltd
Ovarian Cancer
1 trial -
HLX07+carboplatin+pemetrexed
Shanghai Henlius Biotech
HLX07, nsqNSCLC, High EGFR Expression
1 trial -
L2023-K003-002
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma
1 trial -
PLD and Carboplatin
The First People's Hospital of Lianyungang
Non-small Cell Lung Cancer
1 trial -
carboplatin
Cardiff Oncology
Bladder Cancer
1 trial -
cis Platinum/Carboplatin, Pemetrexed Disodium
Shanghai University of Traditional Chinese Medicine
Chemotherapy, Adjuvant
1 trial -
nanoparticle albumin-bound paclitaxel/carboplatin
The First People's Hospital of Lianyungang
Non-small Cell Lung Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.